LogiPharma Europe 2023: Wayne Rothman Discusses Problematic Supply Chain Scenarios

The US president says the levies on pharmaceutical imports are imminent, but won’t take effect for a year to a year and a half.

Alice Valder Curran outlines the steps manufacturers should take to better prepare for upcoming executive actions on drug pricing and market access.

Amid the push for reshoring and fiscal reform, the tariffs are part of a broader effort to rebalance trade and fund domestic initiatives, as the pharma sector awaits potential levies of its own.

Tracy Lopez uncovers the fundamentals pertaining to third-party logistics providers.

The collaborative research initiative will be focused on advancing approaches to enhance the therapeutic efficacy of regulatory T cells and tumor-infiltrating lymphocytes.

The report spotlights China’s rapid biopharma advancement, alongside a GLP-1 surge, caution surrounding M&A, and a rise in biologics.